4-溴-N-异丙基苯胺 | 121086-19-9

• 物质功能分类: 有机原料 - 氨基化合物
• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: 4-溴-N-异丙基苯胺
• 中文别名: N-异丙基-4-溴苯胺
• 英文名称: 4-bromo-N-isopropylaniline
• 英文别名: 4-bromo-N-propan-2-ylaniline
• CAS: 121086-19-9
• 化学式: C₉H₁₂BrN
• mdl: MFCD08691756
• 分子量: 214.105
• InChiKey: GCAYZUSDLCJJAW-UHFFFAOYSA-N

物化性质

• 沸点：
  266.2±23.0 °C(Predicted)
• 密度：
  1.351±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.333
• 拓扑面积：
  12
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 海关编码：
  2921420090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  室温且干燥环境中保存。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 4-Bromo-N-isopropylaniline
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 4-Bromo-N-isopropylaniline
CAS number: 121086-19-9

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H12BrN
Molecular weight: 214.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-溴-N-异丙基苯胺 在 sodium hydroxide 、 三氯化铝 、 dimethyl sulfide borane 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 、 甲苯 为溶剂， 反应 50.5h， 生成 6-cyano-N-isopropyl-4,4-dimethyl-1,2,3,4-tetrahydroquinoline
  参考文献：
  名称：

  氮杂芳烃类化合物的合成，构效关系和RARgamma-配体相互作用。

  摘要：

  合成了在第一个环中含有一个氮原子，在两个芳基环之间具有一个CO连接基团的三个杂芳烃类化合物，并评估了RAR和RXR类维生素A受体的反式激活，肿瘤细胞生长抑制和转谷氨酰胺酶（TGase）的诱导。4-（N，4,4-三甲基-1,2,3,4-四氢喹啉基）苯甲酸乙酯（1）含有N-CH（3）基团，并且活化了所有类视黄醇受体（RARgamma除外）。用类似物4-（N，4,4,7-四甲基-1,2,3，4-四氢喹啉-6-酰氧基）苯甲酸乙酯（2）[添加7-甲基]和乙基4增加环周围的疏水性-（4,4-二甲基-N-异丙基-1,2,3,4-四氢喹啉-6-酰氧基）苯甲酸酯（3）[C-4处的NCH（CH（3））（2）基团增加了效价与RARalpha，RARbeta和RXRalpha的特异性（与1相比），但对RXRbeta和RXRgamma激活的影响很小。尽管1和3无法激活RARgamma，但2确实以与9-顺-视黄酸（9

  DOI：

  10.1021/jm9900974
• 作为产物：
  描述：

  (4-Bromophen-1-yl)(1-methylethylidene)amine 在 sodium tetrahydroborate 、 氨 、 水 作用下， 以 乙醇 为溶剂， 反应 2.17h， 生成 4-溴-N-异丙基苯胺
  参考文献：
  名称：

  Potent direct inhibitors of factor Xa based on the tetrahydroisoquinoline scaffold

  摘要：

  Direct inhibition of coagulation factor Xa (FXa) carries significant promise for developing effective and safe anticoagulants. Although a large number of FXa inhibitors have been studied, each can be classified as either possessing a highly flexible or a rigid core scaffold. We reasoned that an intermediate level of flexibility will provide high selectivity for FXa considering that its active site is less constrained in comparison to thrombin and more constrained as compared to trypsin. We studied several core scaffolds including 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid for direct FXa inhibition. Using a genetic algorithm-based docking and scoring approach, a promising candidate 23 was identified, synthesized, and found to inhibit FXa with a K-i of 28 mu M. Optimization of derivative 23 resulted in the design of a potent dicarboxamide 47, which displayed a K-i of 135 nM. Dicarboxamide 47 displayed at least 1852-fold selectivity for FXa inhibition over other coagulation enzymes and doubled PT and aPTT of human plasma at 17.1 mu M and 20.2 mu M, respectively, which are comparable to those of clinically relevant agents. Dicarboxamide 47 is expected to serve as an excellent lead for further anticoagulant discovery. (C) 2012 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2012.06.032

文献信息

• Alkylation of Amines with Alcohols and Amines by a Single Catalyst under Mild Conditions
  作者：Qingzhu Zou、Chao Wang、Jen Smith、Dong Xue、Jianliang Xiao

  DOI：10.1002/chem.201501109

  日期：2015.6.26

  An efficient catalytic system for the alkylation of amines with either alcohols or amines under mild conditions has been developed, using cyclometallated iridium complexes as catalysts. The method has broad substrate scope, allowing for the synthesis of a diverse range of secondary and tertiary amines with good to excellent yields. By controlling the ratio of substrates, both mono‐ and bis‐alkylated

  使用环金属化铱配合物作为催化剂，已经开发出一种在温和条件下将胺与醇或胺烷基化的有效催化体系。该方法具有广泛的底物范围，允许以良好或优异的产率合成多种范围的仲胺和叔胺。通过控制底物的比例，可以高选择性获得单烷基化胺和双烷基化胺。特别是，甲醇可用作烷基化试剂，选择性地提供N-甲基化产物。对于该反应观察到强溶剂作用。
• Reductive Molybdenum-Catalyzed Direct Amination of Boronic Acids with Nitro Compounds
  作者：Samuel Suárez-Pantiga、Raquel Hernández-Ruiz、Cintia Virumbrales、María R. Pedrosa、Roberto Sanz

  DOI：10.1002/anie.201812806

  日期：2019.2.11

  The synthesis of aromatic amines is of utmost importance in a wide range of chemical contexts. We report a direct amination of boronic acids with nitro compounds to yield (hetero)aryl amines. The novel combination of a dioxomolybdenum(VI) catalyst and triphenylphosphine as inexpensive reductant has revealed to be decisive to achieve this new C−N coupling. Our methodology has proven to be scalable,

  在广泛的化学领域中，芳族胺的合成至关重要。我们报道了硼酸与硝基化合物的直接胺化反应，生成（杂）芳基胺。二氧钼（VI）催化剂和三苯膦作为廉价的还原剂的新颖组合已显示出实现这种新的C-N偶联的决定性作用。我们的方法论已被证明是可扩展的，耐空气和湿气的，高度化学选择性的，并且可以同时结合脂肪族和芳香族硝基化合物。此外，这种芳香族仲胺的一般且分步经济的合成方法可耐受芳基卤化物和羰基化合物，因此与其他芳香族胺合成物具有正交性。
• [EN] WNT PATHWAY MODULATORS<br/>[FR] MODULATEURS DE LA VOIE WNT
  申请人：AGENCY SCIENCE TECH & RES

  公开号：WO2014175832A1

  公开（公告）日：2014-10-30

  The invention provides a compound of structure Ar1-Ar2-X-C(R1R2)-C(=O)-N(R3)-Ar3-Ar4 for modulating WNT activity. In this structure, Ar1, Ar2, Ar3 and Ar4 are, independently, optionally substituted aryl or heteroaryl groups; R1 and R3 are, independently, H or optionally substituted alkyl groups; R2 is H or an optionally substituted alkyl group or an alkylene group which, together with the carbon atom to which it is attached and X, forms a non-aromatic ring or an alkylene group which, together with the carbon atom to which it is attached and X and two adjacent atoms of Ar2, forms a non-aromatic ring; X is O, CR4R5, N or NR4, wherein if X is N, it is bonded to R2; R4 is H, optionally substituted alkyl or an alkylene chain, optionally containing a heteroatom and/or a carbonyl group, which, together with the C or N to which it is attached and two adjacent atoms of Ar2, forms a non-aromatic ring; R5 is H, NH2 or an optionally substituted alkyl group.

  该发明提供了一种结构为Ar1-Ar2-X-C(R1R2)-C(=O)-N(R3)-Ar3-Ar4的化合物，用于调节WNT活性。在这种结构中，Ar1、Ar2、Ar3和Ar4分别是可选择取代的芳基或杂环芳基；R1和R3分别是H或可选择取代的烷基；R2是H或可选择取代的烷基或与其连接的碳原子和X形成非芳香环的烷基，或者与其连接的碳原子、X和Ar2的两个相邻原子形成非芳香环的烷基；X是O、CR4R5、N或NR4，如果X是N，则与R2相结合；R4是H、可选择取代的烷基或含有杂原子和/或羰基的烷基链，与其连接的C或N以及Ar2的两个相邻原子形成非芳香环；R5是H、NH2或可选择取代的烷基。
• Synthesis and Structural Analysis of the Anilides of Glucuronic Acid and Orientation of the Groups on the Carbohydrate Scaffolding
  作者：Manuela Tosin、Colin O'Brien、Geraldine M. Fitzpatrick、Helge Müller-Bunz、W. Kenneth Glass、Paul V. Murphy

  DOI：10.1021/jo0501994

  日期：2005.5.1

  synthesis of anilides derived from glucuronic acid is described. Secondary anilides had a Z configuration in the solid state and showed intramolecular and intermolecular hydrogen bonding. However, on the basis of NMR and IR studies, there was generally no evidence for the same hydrogen bonding in solution. Tertiary anilides showed a strong preference for the E configuration on the basis of NOE studies and molecular

  描述了衍生自葡糖醛酸的酸酐的合成。仲酸酐在固态具有Z构型，并显示出分子内和分子间的氢键。但是，基于NMR和IR研究，通常没有证据表明溶液中存在相同的氢键。在NOE研究和分子力学计算的基础上，叔酸酐显示出对E构型的强烈偏好。仲酸酐的烷基化引起构型转换，该构型转换改变了芳族基团相对于吡喃糖的取向，这与碳水化合物支架上药效基团的呈递或取向有关。
• Synthesis and evaluation of [11C]RU40555, a selective glucocorticoid receptor antagonist
  作者：Takahiro Matsuya、Hiroyuki Takamatsu、Yoshihiro Murakami、Akihiro Noda、Kazuhiko Osoda、Rikiya Ichise、Yuji Awaga、Shintaro Nishimura

  DOI：10.1002/jlcr.958

  日期：2005.8

  We demonstrated the synthesis of carbon-11 labeled 17-α-hydroxy-11-β-/4-/[methyl]-[1-methylethyl]-aminophenyl/-17α-[prop-1-ynyl]esta-4-9-diene-3-one (RU40555), a selective glucocorticoid receptor (GR) antagonist, and examined the in vivo profile of [11C]RU40555. [11C]RU40555 was synthesized by direct N-methylation with [11C]CH3OTf at 60°C for 5 min and an injectable solution of [11C]RU40555 was obtained in 31 min at the end of bombardment. The decay-corrected radiochemical yield was 19%, the specific radioactivity was 57.5±14.0 GBq/µmol, and the radiochemical purity was more than 99% as determined by HPLC. In rat experiments, the effects of adrenalectomy (ADX) on brain accumulation of [11C]RU40555 were examined. ADX significantly decreased plasma corticosterone levels, and significantly increased brain accumulation of [11C]RU40555. We succeeded in developing a rapid automated synthesis method for [11C]RU40555, a GR antagonist, and showed [11C]RU40555 had a potential as a PET tracer for mapping GR. Copyright © 2005 John Wiley & Sons, Ltd.

  我们展示了碳-11标记的17-α-羟基-11-β-/4-/[甲基]-[1-甲基乙基]-氨基苯基/-17α-[丙-1-炔基]酯-4-9-二烯-3-酮（RU40555）这一特定糖皮质激素受体（GR）拮抗剂的合成，并检查了[11C]RU40555的体内特性。[11C]RU40555通过在60°C下用[11C]CH3OTf直接进行N-甲基化合成，合成时间为5分钟，并在轰击结束后31分钟获得可注射的[11C]RU40555溶液。经衰变校正后的放射化学产率为19%，比放射活度为57.5±14.0 GBq/µmol，放射化学纯度通过高效液相色谱法（HPLC）测定超过99%。在大鼠实验中，我们研究了肾上腺切除术（ADX）对[11C]RU40555在脑中的积累的影响。ADX显著降低了血浆皮质酮水平，并显著增加了[11C]RU40555在脑中的积累。我们成功开发了一种快速的自动合成方法来合成GR拮抗剂[11C]RU40555，并显示[11C]RU40555作为PET示踪剂用于映射GR具有潜力。版权所有 © 2005 John Wiley & Sons, Ltd.